Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Chronic Heart Failure

  Free Subscription


Articles published in Cardiovasc Res

Retrieve available abstracts of 38 articles:
HTML format
Text format



Single Articles


    October 2018
  1. SUEN CM, Chaudhary KR, Deng Y, Jiang B, et al
    Fischer rats exhibit maladaptive structural and molecular right ventricular remodelling in severe pulmonary hypertension: a genetically prone model for right heart failure.
    Cardiovasc Res. 2018 Oct 24. pii: 5144198. doi: 10.1093.
    PubMed     Text format     Abstract available


  2. ROE AT, Ruud M, Espe EK, Manfra O, et al
    Regional diastolic dysfunction in post-infarction heart failure: role of local mechanical load and SERCA expression.
    Cardiovasc Res. 2018 Oct 23. pii: 5142689. doi: 10.1093.
    PubMed     Text format     Abstract available


    August 2018
  3. COPPINI R, Ferrantini C
    NaV1.8: a novel contributor to cardiac arrhythmogenesis in heart failure.
    Cardiovasc Res. 2018 Aug 29. pii: 5086354. doi: 10.1093.
    PubMed     Text format    


  4. BASTUG-OZEL Z, Wright PT, Kraft AE, Pavlovic D, et al
    Heart failure leads to altered beta2-adrenoceptor/cAMP dynamics in the sarcolemmal phospholemman/Na,K ATPase microdomain: Bastug et al. Phospholemman cAMP microdomain.
    Cardiovasc Res. 2018 Aug 27. pii: 5079901. doi: 10.1093.
    PubMed     Text format     Abstract available


    July 2018
  5. POL AV, Gil A, Tromp J, Sillje HHW, et al
    OPLAH ablation leads to accumulation of 5-oxoproline, oxidative stress, fibrosis and elevated fillings pressures: a murine model for heart failure with a preserved ejection fraction.
    Cardiovasc Res. 2018 Jul 19. pii: 5056075. doi: 10.1093.
    PubMed     Text format     Abstract available


  6. PANAHI M, Papanikolaou A, Torabi A, Zhang JG, et al
    Immunomodulatory interventions in myocardial infarction and heart failure: a systematic review of clinical trials and meta-analysis of IL-1 inhibition.
    Cardiovasc Res. 2018 Jul 14. pii: 5054000. doi: 10.1093.
    PubMed     Text format     Abstract available


  7. DOBREV D, Fender AC, Wehrens XHT
    Pro-arrhythmic RyR2 channels in heart failure: do their localisation and mechanism of activation really matter?
    Cardiovasc Res. 2018 Jul 3. pii: 5048462. doi: 10.1093.
    PubMed     Text format    


    June 2018
  8. IDRES S, Perrin G, Domergue V, Lefebvre F, et al
    Contribution of BKCa channels to vascular tone regulation by PDE3 and PDE4 is lost in heart failure.
    Cardiovasc Res. 2018 Jun 23. pii: 5043286. doi: 10.1093.
    PubMed     Text format     Abstract available


  9. KARKKAINEN O, Tuomainen T, Mutikainen M, Lehtonen M, et al
    Heart specific PGC-1alpha deletion identifies metabolome of cardiac restricted metabolic heart failure.
    Cardiovasc Res. 2018 Jun 20. pii: 5040494. doi: 10.1093.
    PubMed     Text format     Abstract available


  10. NATTEL S
    Catheter ablation of atrial fibrillation and outcomes in heart failure patients: seeking the treasure in the CASTLE.
    Cardiovasc Res. 2018;114:e50-e52.
    PubMed     Text format    


    April 2018
  11. VAN DER ENDE MY, Said MA, van Veldhuisen DJ, Verweij N, et al
    Genome Wide Studies of Heart Failure and Endophenotypes: lessons learned and future directions.
    Cardiovasc Res. 2018 Apr 18. pii: 4975446. doi: 10.1093.
    PubMed     Text format     Abstract available


  12. DRIES E, Santiago DJ, Gilbert G, Lenaerts I, et al
    Hyperactive ryanodine receptors in human heart failure and ischemic cardiomyopathy reside outside of couplons.
    Cardiovasc Res. 2018 Apr 14. pii: 4970798. doi: 10.1093.
    PubMed     Text format     Abstract available


  13. BORGOGNONE A, Shantsila E, Worrall SM, Prompunt E, et al
    Nitrite circumvents platelet resistance to nitric oxide in patients with heart failure preserved ejection fraction and chronic atrial fibrillation.
    Cardiovasc Res. 2018 Apr 12. pii: 4969512. doi: 10.1093.
    PubMed     Text format     Abstract available


    March 2018
  14. DE ROSA M, Gambardella J, Shu J, Santulli G, et al
    Dietary Fat is a Key Determinant in Balancing Mitochondrial Dynamics in Heart Failure: A Novel Mechanism Underlying the Obesity Paradox.
    Cardiovasc Res. 2018 Mar 22. pii: 4951453. doi: 10.1093.
    PubMed     Text format    


    November 2017
  15. FLORIJN BW, Bijkerk R, van der Veer E, van Zonneveld AJ, et al
    Gender and cardiovascular disease: Are sex-biased miRNA networks a driving force behind heart failure with preserved ejection fraction in women?
    Cardiovasc Res. 2017 Nov 24. pii: 4657087. doi: 10.1093.
    PubMed     Text format     Abstract available


    September 2017
  16. RIPPLINGER CM
    From drugs to devices and back again: chemical vagal nerve stimulation for the treatment of heart failure.
    Cardiovasc Res. 2017;113:1270-1272.
    PubMed     Text format    


    July 2017
  17. FRASER AG, Gillebert TC, Leite-Moreira AF
    Ventricular-arterial coupling in heart failure with preserved ejection fraction: the devil is in the details.
    Cardiovasc Res. 2017;113:844-846.
    PubMed     Text format    


    June 2017
  18. SCHOBESBERGER S, Wright P, Tokar S, Bhargava A, et al
    T-tubule remodelling disturbs localized beta2-adrenergic signalling in rat ventricular myocytes during the progression of heart failure.
    Cardiovasc Res. 2017;113:770-782.
    PubMed     Text format     Abstract available


    May 2017
  19. ABDURRACHIM D, Nabben M, Hoerr V, Kuhlmann MT, et al
    Diabetic db/db mice do not develop heart failure upon pressure overload: A longitudinal in vivo PET, MRI, and MRS study on cardiac metabolic, structural, and functional adaptations.
    Cardiovasc Res. 2017 May 26. doi: 10.1093.
    PubMed     Text format     Abstract available


  20. VILLALBA-ORERO M, Lopez-Olaneta MM, Gonzalez-Lopez E, Padron-Barthe L, et al
    Lung ultrasound as a translational approach for non-invasive assessment of heart failure with reduced or preserved ejection fraction in mice.
    Cardiovasc Res. 2017 May 4. doi: 10.1093.
    PubMed     Text format     Abstract available


  21. GARROTT K, Dyavanapalli J, Cauley E, Kate Dwyer M, et al
    Chronic activation of hypothalamic oxytocin neurons improves cardiac function during left ventricular hypertrophy-induced heart failure.
    Cardiovasc Res. 2017 May 2. doi: 10.1093.
    PubMed     Text format     Abstract available


  22. LI J, Yousefi K, Ding W, Singh J, et al
    Osteopontin RNA aptamer can prevent and reverse pressure overload-induced heart failure.
    Cardiovasc Res. 2017;113:633-643.
    PubMed     Text format     Abstract available


  23. NONHOFF J, Ricke-Hoch M, Mueller M, Stapel B, et al
    Serelaxin treatment promotes adaptive hypertrophy but does not prevent heart failure in experimental peripartum cardiomyopathy.
    Cardiovasc Res. 2017;113:598-608.
    PubMed     Text format     Abstract available


  24. HAUSENLOY DJ, Garcia-Dorado D, Botker HE, Davidson SM, et al
    Novel targets and future strategies for acute cardioprotection: Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart.
    Cardiovasc Res. 2017;113:564-585.
    PubMed     Text format     Abstract available


    April 2017
  25. CROSSMAN DJ, Shen X, Jullig M, Munro M, et al
    Increased collagen within the transverse tubules in human heart failure.
    Cardiovasc Res. 2017 Apr 20. doi: 10.1093.
    PubMed     Text format     Abstract available


  26. PEREZ DEL VILLAR C, Savvatis K, Lopez B, Kasner M, et al
    Impact of acute hypertension transients on diastolic function in patients with heart failure with preserved ejection fraction.
    Cardiovasc Res. 2017 Apr 11. doi: 10.1093.
    PubMed     Text format     Abstract available


    March 2017
  27. SATO T, Sato C, Kadowaki A, Watanabe H, et al
    ELABELA - APJ axis protects from pressure overload heart failure and Angiotensin II-induced cardiac damage.
    Cardiovasc Res. 2017 Mar 23. doi: 10.1093.
    PubMed     Text format     Abstract available


    February 2017
  28. LI J, Yousefi K, Ding W, Singh J, et al
    Osteopontin RNA Aptamer Can Prevent and Reverse Pressure Overload-Induced Heart Failure.
    Cardiovasc Res. 2017 Feb 1. doi: 10.1093.
    PubMed     Text format    


  29. GRECO S, Zaccagnini G, Fuschi P, Voellenkle C, et al
    Increased Bace1-As Long Noncoding Rna And beta-Amyloid Levels In Heart Failure.
    Cardiovasc Res. 2017 Feb 1. doi: 10.1093.
    PubMed     Text format    


  30. ELIA L, Quintavalle M, Condorelli G
    Circular RNAs and heart failure: new players for an old disease.
    Cardiovasc Res. 2017 Feb 1. doi: 10.1093.
    PubMed     Text format    


    January 2017
  31. NONHOFF J, Ricke-Hoch M, Mueller M, Stapel B, et al
    Serelaxin treatment promotes adaptive hypertrophy but does not prevent heart failure in experimental peripartum cardiomyopathy.
    Cardiovasc Res. 2017 Jan 20. pii: cvw245. doi: 10.1093.
    PubMed     Text format     Abstract available


    November 2016
  32. LI L, Li J, Drum BM, Chen Y, et al
    Loss of AKAP150 promotes pathological remodelling and heart failure propensity by disrupting calcium cycling and contractile reserve.
    Cardiovasc Res. 2016.
    PubMed     Text format     Abstract available


    July 2016
  33. LIU L, An X, Li Z, Song Y, et al
    The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy.
    Cardiovasc Res. 2016;111:56-65.
    PubMed     Text format     Abstract available


  34. SCHEID LM, Mosqueira M, Hein S, Kossack M, et al
    Essential light chain S195 phosphorylation is required for cardiac adaptation under physical stress.
    Cardiovasc Res. 2016;111:44-55.
    PubMed     Text format     Abstract available


    June 2016
  35. HILLE S, Dierck F, Kuhl C, Sosna J, et al
    Dyrk1a regulates the cardiomyocyte cell cycle via D-cyclin-dependent Rb/E2f-signalling.
    Cardiovasc Res. 2016;110:381-94.
    PubMed     Text format     Abstract available


    May 2016
  36. KOOIJ V, Viswanathan MC, Lee DI, Rainer PP, et al
    Profilin modulates sarcomeric organization and mediates cardiomyocyte hypertrophy.
    Cardiovasc Res. 2016;110:238-48.
    PubMed     Text format     Abstract available


    January 2016
  37. GOH KY, Qu J, Hong H, Liu T, et al
    Impaired mitochondrial network excitability in failing guinea-pig cardiomyocytes.
    Cardiovasc Res. 2016;109:79-89.
    PubMed     Text format     Abstract available


    December 2015
  38. KUMAGAI S, Nakayama H, Fujimoto M, Honda H, et al
    Myeloid cell-derived LRG attenuates adverse cardiac remodelling after myocardial infarction.
    Cardiovasc Res. 2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: